Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Intra-Cellular Therapies, Inc.
The study will be conducted in three periods: * Screening Period (up to 2 weeks) during which patient eligibility will be assessed; * Double-blind Treatment Period (6 weeks) in which all patients will be randomized to receive placebo or lumateperone 42mg/day in 1:1 ratio. * Safety Follow-up Period (1 week) in which all patients will return to the clinic for a safety follow-up visit approximately one week after the last dose of study treatment.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted